Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Mr. Andrew R. RobbinsPresident, CEO & Director | -160,00k | 0,00 | Other Disposition | - | 472,50k | -25,30% |
| 2026-03-31 | Fairmount Funds Management LLCSociété | -7,00M | 242,62M | Derivative Exercise and Sale | 34,66 | 5,50M | - |
| 2026-01-22 | Fairmount Funds Management LLCSociété | -3,50M | 127,40M | Vente | 36,40 | 5,50M | -38,87% |
| 2025-12-26 | Dr. Jessica SachsChief Medical Officer | -82,64k | 3,20M | Vente | 38,70 | 83,94k | -49,61% |
| 2025-12-26 | Dr. John Edward RobinsonChief Scientific Officer | -90,00k | 3,49M | Vente | 38,74 | 90,00k | -50,00% |
| 2025-12-26 | Mr. Evan D. KearnsChief Legal Officer & Corporate Secretary | -65,00k | 2,52M | Vente | 38,70 | 69,40k | -48,36% |
| 2025-12-26 | Mr. John L. GreenCFO & Principal Accounting Officer | -77,00k | 2,98M | Vente | 38,68 | 81,83k | -48,48% |
| 2025-12-17 | Dr. John Edward RobinsonChief Scientific Officer | -140,00k | 5,52M | Sale to Issuer | 39,45 | 180,00k | -43,75% |
| 2025-12-17 | Mr. Andrew R. RobbinsPresident, CEO & Director | -367,50k | 14,50M | Sale to Issuer | 39,45 | 472,50k | -43,75% |
| 2025-12-17 | Dr. Jessica SachsChief Medical Officer | -154,72k | 6,10M | Sale to Issuer | 39,45 | 166,58k | -48,15% |
| 2025-12-17 | Mr. Evan D. KearnsChief Legal Officer & Corporate Secretary | -125,60k | 4,95M | Sale to Issuer | 39,45 | 134,40k | -48,31% |
| 2025-12-17 | Mr. John L. GreenCFO & Principal Accounting Officer | -145,01k | 5,72M | Sale to Issuer | 39,45 | 158,83k | -47,72% |
| 2025-12-17 | Mr. Cole PinnowChief Commercial Officer | -94,80k | 3,74M | Sale to Issuer | 39,45 | 166,65k | -36,26% |
| 2025-07-10 | Fairmount Funds Management LLCSociété | 2,78M | 25,00M | Achat | 9,00 | 9,00M | 44,62% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.